These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1829682)

  • 1. Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine.
    Barone P; Palma V; DeBartolomeis A; Tedeschi E; Muscettola G; Campanella G
    Eur J Pharmacol; 1991 Mar; 195(1):157-62. PubMed ID: 1829682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
    George B; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):481-8. PubMed ID: 9413831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
    Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
    Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.
    al-Tajir G; Chandler CJ; Starr BS; Starr MS
    Neuropharmacology; 1990 Jul; 29(7):657-61. PubMed ID: 1974713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors.
    Alam AM; Starr MS
    Eur J Pharmacol; 1992 Nov; 222(2-3):227-32. PubMed ID: 1451735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat.
    Alam AM; Starr MS
    Neuroscience; 1994 Jun; 60(4):1039-47. PubMed ID: 7936204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic regulation of epileptic activity.
    Barone P; Palma V; de Bartolomeis A; Cicarelli G; Campanella G
    Neurochem Int; 1992 Mar; 20 Suppl():245S-249S. PubMed ID: 1365435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
    Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
    Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCH 23390: the first selective dopamine D1-like receptor antagonist.
    Bourne JA
    CNS Drug Rev; 2001; 7(4):399-414. PubMed ID: 11830757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.
    Koob GF; Le HT; Creese I
    Neurosci Lett; 1987 Aug; 79(3):315-20. PubMed ID: 2958724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat.
    Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF
    Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant-conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning.
    Martin-Iverson MT; McManus DJ
    Brain Res; 1990 Jun; 521(1-2):175-84. PubMed ID: 2145055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
    Daly SA; Waddington JL
    Eur J Pharmacol; 1992 Mar; 213(2):251-8. PubMed ID: 1387846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant action of SCH 23390 in the striatum of the rat.
    al-Tajir G; Starr MS
    Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.